Medicine and Dentistry
Antigen Specificity
100%
Ex Vivo
100%
Regulatory T Cell
100%
Infusion
100%
Immunosuppressive Drug
75%
Immune Response
50%
Kidney Graft
50%
Infection
50%
Medical Research
50%
Cyclic GMP
50%
Tolerance in Transplantation
25%
Clinical Trial
25%
Sensitization
25%
Graft Rejection
25%
Guanosine Phosphate
25%
Immunological Tolerance
25%
In Vitro
25%
Adverse Event
25%
Alloantigen
25%
Diabetes
25%
Tissue Transplantation
25%
Organ Transplantation
25%
Cancer
25%
T Cell
25%
Nephrotoxicity
25%
Living Donors
25%
Biopsy Technique
25%
Diseases
25%
Keyphrases
Tolerance Induction
100%
Treg
100%
Transplantation Tolerance
100%
Antigen-specific T Cells
100%
Donor-specific
25%
Antigen-specific
25%
Cyclic GMP
16%
Immunosuppressive Agents
16%
Kidney Transplant Recipients
16%
Infection Rate
16%
Medical Research
16%
Immune Response
16%
Transplantation
16%
Escalating Dose
8%
Protocol Biopsy
8%
Holy Grail
8%
Multiple Benefits
8%
GMP Grade
8%
In Vivo Safety
8%
CD4+CD25+ T Cells
8%
Cumulative Toxicity
8%
Unique Culture
8%
Research Trust
8%
Historical Controls
8%
Immunosuppressive Drugs
8%
Malignancy
8%
Living Donor Kidney Transplantation
8%
Adverse Events
8%
Large-scale Isolation
8%
Safety Trial
8%
Quality of Life Improvement
8%
Unresponsiveness
8%
Hypertension
8%
Graft Rejection
8%
Phase 1 Trial
8%
Immunologic Tolerance
8%
Efficacy Trial
8%
Length of Life
8%
In Vivo Efficacy
8%
Therapeutic Potential
8%
Diabetes
8%
Clinical Practice
8%
Alloantigen
8%
Nephrotoxicity
8%
Phase I Clinical Trial
8%
Healthcare
8%
Culture System
8%
Transplantation Model
8%
High Reward
8%
Transplant Recipients
8%
Organ Transplantation
8%
Tissue Transplantation
8%
Immunology and Microbiology
Regulatory T Cell
100%
Antigen Specificity
100%
Immunosuppressive Drug
23%
Immune Response
15%
Immune Tolerance
7%
Sensitization
7%
Tolerance in Transplantation
7%
CD4
7%
Alloantigen
7%
CD25
7%
FOXP3
7%
T Cell
7%